Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| MEDICINES CO /DE | 3,447 | reported | 28 Feb 2006 | tx 2+50,566 |
| IGI INC | 2,000 | reported | 04 Jan 2021 | tx 14+198,254 |
| Merck & Co., Inc. | 0 | reported | 03 Nov 2009 | tx 21+373,300−373,300 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 04 Jan 2021 | GRANT_AWARD | IGI INC | 2,000 | 0.00 USD | deriv |
| 02 Jan 2020 | GRANT_AWARD | IGI INC | 20,000 | 0.00 USD | deriv |
| 02 Oct 2019 | GRANT_AWARD | IGI INC | 12,784 | 0.00 USD | deriv |
| 01 Jul 2019 | GRANT_AWARD | IGI INC | 17,308 | 0.00 USD | deriv |
| 13 May 2019 | GRANT_AWARD | IGI INC | 13,081 | 0.00 USD | deriv |
| 13 May 2019 | GRANT_AWARD | IGI INC | 13,081 | 0.00 USD | deriv |
| 02 Jan 2019 | GRANT_AWARD | IGI INC | 20,000 | 0.00 USD | deriv |
| 02 Jan 2018 | GRANT_AWARD | IGI INC | 20,000 | 0.00 USD | deriv |
| 10 Nov 2017 | PURCHASE | IGI INC | 300 | 3.61 USD | |
| 10 Nov 2017 | PURCHASE | IGI INC | 2,900 | 3.62 USD | |
| 10 Nov 2017 | PURCHASE | IGI INC | 1,800 | 3.62 USD | |
| 03 Jan 2017 | GRANT_AWARD | IGI INC | 20,000 | 0.00 USD | deriv |
| 02 Jan 2015 | GRANT_AWARD | IGI INC | 35,000 | 0.00 USD | deriv |
| 04 Jan 2016 | GRANT_AWARD | IGI INC | 20,000 | 0.00 USD | deriv |
| 03 Nov 2009 | OTHER | Merck & Co., Inc. | 10,619 | — | |
| 03 Nov 2009 | OTHER | Merck & Co., Inc. | 57,300 | — | deriv |
| 03 Nov 2009 | OTHER | Merck & Co., Inc. | 20,000 | — | deriv |
| 03 Nov 2009 | OTHER | Merck & Co., Inc. | 58,000 | — | deriv |
| 03 Nov 2009 | OTHER | Merck & Co., Inc. | 50,000 | — | deriv |
| 03 Nov 2009 | OTHER | Merck & Co., Inc. | 80,000 | — | deriv |
| 03 Nov 2009 | OTHER | Merck & Co., Inc. | 75,000 | — | deriv |
| 01 May 2009 | GRANT_AWARD | Merck & Co., Inc. | 57,300 | — | deriv |
| 01 Apr 2009 | EXERCISE | Merck & Co., Inc. | 6,500 | 0.00 USD | |
| 01 Apr 2009 | TAX_WITHHOLDING | Merck & Co., Inc. | 2,363 | 23.70 USD | |
| 01 Apr 2009 | EXERCISE | Merck & Co., Inc. | 6,500 | — | deriv |